A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
Clinical trial NCT04605211 · COMPLETED
Trial details
- NCT number
- NCT04605211
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2022-09-30
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.